Kexing Biopharm Co., Ltd. (SHA:688136)
China
· Delayed Price · Currency is CNY 30.75
+0.88 (2.95%)
Mar 10, 2026, 11:24 AM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 5.92 billion as of March 9, 2026. Its market cap has increased by 57.49% in one year.
Market Cap
5.92B
Enterprise Value
6.70B
Revenue
1.54B
Ranking
n/a
PE Ratio
36.88
Stock Price
30.75
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 5.92B, a decrease of -27.38%. That is a compound annual growth rate of -5.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shouyao Holdings (Beijing) Co., LTD. | 5.86B |
| Novogene | 5.84B |
| Xiangxue Pharmaceutical | 6.25B |
| R&G PharmaStudies | 6.30B |
| GemPharmatech | 6.30B |
| PharmaResources (Shanghai) | 5.64B |
| Shanghai OPM Biosciences | 6.37B |
| Beijing Konruns Pharmaceutical | 6.50B |